Trial investigating potential treatment for fatigue relief in people with long COVID reports results

Researchers from the University of Oxford have reported findings from a Phase 2 clinical trial investigating the efficacy of an investigational treatment against long COVID fatigue.The study (reported in Lancet eClinical Medicine) found participants given the treatment, developed by US pharmaceutical company Axcella Therapeutics, reported feeling less fatigued than those given

Related Keywords

Betty Raman ,Radcliffe Department Of Medicine At Oxford University ,Associate Professor Betty Raman ,Radcliffe Department ,Oxford University ,Margaret Koziel ,Axcella Chief Medical Officer ,